Pancreatin

DRUG3 trials

Sponsors

Solvay Pharmaceuticals, Abbott Products

Conditions

GastrectomyPancreatic Exocrine InsufficiencyPancreatic Insufficiency

Phase 3

Creon 40,000 for Treatment of PEI (Pancreatic Exocrine Insufficiency) Due to Chronic Pancreatitis

CompletedNCT00705978

Abbott ProductsPancreatic Insufficiency

Start: 2008-06-30End: 2010-05-31Updated: 2011-08-18

Evaluation of Safety and Tolerability of Creon Micro in Children Younger Than Four Years With Pancreatic Exocrine Insufficiency

CompletedNCT01747330

Abbott ProductsPancreatic Exocrine Insufficiency

Start: 2012-06-30End: 2012-12-31Updated: 2014-07-15

Phase 4

Gastrectomy Study: Study to Investigate the Effect of Creon 25000 Minimicrospheres on Body Mass Index (BMI) in Patients After Gastrectomy

CompletedNCT00160186

Solvay PharmaceuticalsGastrectomy

Start: 2003-12-31End: 2006-05-31Target: 40Updated: 2008-03-31